[1]
L. Rashid, “Treatment-resistant hypophosphataemia after ferric carboxymaltose: expanding the spectrum of 6H syndrome (hypophosphataemia, hyperphosphaturia, hypovitaminosis D, hypocalcaemia, secondary hyperparathyroidism, high fibroblast growth factor-23)”, EJCRIM, vol. 12, no. 11, Oct. 2025, doi: 10.12890/2025_005824.